A new trading day began on Monday, with Vaxart Inc (NASDAQ: VXRT) stock price down -8.81% from the previous day of trading, before settling in for the closing price of $0.79. VXRT’s price has ranged from $0.52 to $1.54 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 1642.83%. Meanwhile, its annual earnings per share averaged 32.16%. With a float of $225.47 million, this company’s outstanding shares have now reached $227.48 million.
Let’s determine the extent of company efficiency that accounts for 125 employees. In terms of profitability, gross margin is -18.02%, operating margin of -427.81%, and the pretax margin is -430.07%.
Vaxart Inc (VXRT) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vaxart Inc is 0.89%, while institutional ownership is 23.27%. The most recent insider transaction that took place on Jun 18 ’24, was worth 13,578. In this transaction Director of this company bought 20,000 shares at a rate of $0.68, taking the stock ownership to the 78,125 shares.
Vaxart Inc (VXRT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 32.16% per share during the next fiscal year.
Vaxart Inc (NASDAQ: VXRT) Trading Performance Indicators
Here are Vaxart Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.83. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.41, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of Vaxart Inc (VXRT)
Looking closely at Vaxart Inc (NASDAQ: VXRT), its last 5-days average volume was 3.1 million, which is a drop from its year-to-date volume of 3.37 million. As of the previous 9 days, the stock’s Stochastic %D was 43.28%. Additionally, its Average True Range was 0.08.
During the past 100 days, Vaxart Inc’s (VXRT) raw stochastic average was set at 34.65%, which indicates a significant decrease from 34.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 135.56% in the past 14 days, which was higher than the 79.40% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6655, while its 200-day Moving Average is $0.7698. However, in the short run, Vaxart Inc’s stock first resistance to watch stands at $0.7623. Second resistance stands at $0.8044. The third major resistance level sits at $0.8306. If the price goes on to break the first support level at $0.6940, it is likely to go to the next support level at $0.6678. Now, if the price goes above the second support level, the third support stands at $0.6257.
Vaxart Inc (NASDAQ: VXRT) Key Stats
With a market capitalization of 163.83 million, the company has a total of 227,480K Shares Outstanding. Currently, annual sales are 7,380 K while annual income is -82,470 K. The company’s previous quarter sales were 4,930 K while its latest quarter income was -14,080 K.
